From Preclinical Pathway to Commercialization: Integrating the CKD Patient Voice at Every Stage of Drug Development
- Embedding patient advocacy organizations from preclinical pathway selection through to commercialization to ensure patient-centred design
- Co-developing study protocols informed by large-scale patient surveys and real-world insights to strengthen trial relevance
- Engaging patients early to refine endpoints, inclusion criteria, and study feasibility based on lived experience
- Creating ongoing partnerships between patients, scientists, and sponsors that inform both trial governance and long-term development strategy